📅Offer Date: 17 May 2023 – 19 May 2023
Data sourced from BSE & NSE · Last updated
Remus Pharmaceuticals Limited IPO was subscribed 57.21x in total when bidding closed on 19 May 2023, with 0.00x in the QIB category, 0.00x in NII, 49.81x in retail. The issue ran from 17 May 2023 to 19 May 2023 at a price band of ₹1150.00–₹1229.00 per share.
Times subscribed by category against the 1× line.
Based on retail subscription (49.81x). Final allotment decided by registrar's computerised lottery.
| Category | Offer | Applied | Times |
|---|---|---|---|
| Retail | 19,44,118 | 9,68,36,518 | 49.81x |
| Total | 34,70,400 | 19,85,41,584 | 57.21x |
| QIB / NII | 3,47,040 | 0 | 0.00x |
| Category | Offered | Demand | Times |
|---|---|---|---|
| Retail | 238.93 | 11901.21 | 49.81x |
| QIB / NII | 42.65 | — | 0.00x |
| Total | 281.58 | 11901.21 | 57.21x |
Values derived from share count × issue price (₹1229.00)
Because Remus Pharmaceuticals Limited closed oversubscribed, allotment follows the applicable category and exchange rules. A high subscription figure reflects strong demand but does not guarantee a premium listing, and a low figure does not guarantee a discount. This page is for information only and is not investment advice.
NSE SME listed · Bidding data sourced from BSE & NSE under SEBI ICDR regulations.